Thymidine Kinase 2 Deficiency: Clinical Trials

2 trials for Thymidine Kinase 2 Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1
Phase 11Active not recruiting 1

Follow Thymidine Kinase 2 Deficiency: new trials by email Literature Review of Thymidine Kinase 2 Deficiency trials Research Report on Thymidine Kinase 2 Deficiency

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency
doxecitine and doxribtimine - Thymidine Kinase 2 Deficiency
Phase 2CompletedUCB BIOSCIENCES, Inc.472019-07-052026-09-08
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
Thymidine - Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, Thymidine Kinase 2 Deficiency
Phase 1 / Phase 2Active not recruitingColumbia University232017-05-162026-01-28

Narrower conditions

Mitochondrial Diseases (1)  ·  Muscle Weakness (1)  ·  Muscular Atrophy (1)

Broader conditions

Atrophy (1)  ·  Metabolic Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Deoxycytidine (2)  ·  Thymidine (2)

Sponsors

Columbia University (1)  ·  UCB BIOSCIENCES, Inc. (1)

Countries

United States (2)  ·  Israel (1)  ·  Spain (1)

Top investigators

Michio Hirano, MD (1)

Results publications

PMID 23932787, PMID 24968719, PMID 28318037, PMID 29602790, PMID 33246973

NIH funding

2018 (1), 2023 (1)